Mega Lifesciences Public Company Limited (SET: MEGA)
Health Care · Pharmaceuticals · TH
฿33.75
-2.88% today · +7.1% 1Y
Mega Lifesciences Public Company Limited (SET: MEGA) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $876.44M and employs 900 people.
Over the last twelve months the share price has gained 7.1%, trading between 27.75 and 40.00.
Tweenvest scores Mega Lifesciences Public Company Limited across four factors: quality 90/100, value 73/100, growth 32/100, dividend 100/100. Its strongest factor is dividend.
MEGA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $876.44M
- Revenue (TTM)
- $436.76M
- P/E
- 13.43
- EPS
- 2.51
- Dividend yield
- 5.04%
- Beta (5Y)
- 0.32
- 52-week high
- ฿40.00
- 52-week low
- ฿27.75
- Avg volume (3M)
- —
- Shares outstanding
- 871.87M
- Employees
- 900
- Next earnings
- —
About Mega Lifesciences Public Company Limited
Established in Bangkok, Thailand, in 1982, Mega Lifesciences Public Company Limited, a subsidiary of Unistretch Limited, operates as a comprehensive pharmaceutical and wellness enterprise. Its primary activities encompass the development, promotion, and distribution of a broad spectrum of health-related products, including nutritional supplements, prescription medicines, over-the-counter (OTC) remedies, botanical solutions, vitamins, and everyday consumer goods. The company structures its operations across three main divisions: Brands, Distribution, and Original Equipment Manufacture. Mega Lifesciences offers an extensive array of complementary medicines targeting various health concerns such as bone and joint health, pediatric care, diabetes management, cardiovascular support, digestive and liver wellness, skin health, weight management, overall well-being, men's and women's specific needs, and sports nutrition. Its OTC portfolio addresses common issues like gastrointestinal discomfort and pain. Furthermore, the prescription drug division covers crucial therapeutic areas including iron deficiency, anticoagulation, diabetology, cardiology, dermatology, gastroenterology, neurology, pain relief, osteoporosis, respiratory conditions, urology, oncology, and nephrology. Beyond its proprietary product lines, the company also provides third-party logistical and marketing services. Additionally, Mega Lifesciences is involved in managing wellness centers and offers specialized services in software design, development, and related technological solutions. The company maintains a significant global footprint, with operations spanning the Asia Pacific region, the Middle East, Africa, and the Commonwealth of Independent States.
- ISIN
- TH4984010009
- Founded
- 1982
- Listed since
- Nov 19, 2013
- Exchange
- The Stock Exchange of Thailand
- Currency
- THB
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Procter & Gamble Health LimitedBSE: 500126 | $897.79M | Rs5,232.00 | -1.32% |
| MedinCell S.A.ENXTPA: MEDCL | $897.28M | €26.28 | +18.38% |
| Hainan Haiyao Co., Ltd.SZSE: 000566 | $893.56M | CN¥4.62 | -1.49% |
| Sanofi Consumer Healthcare India LimitedNSEI: SANOFICONR | $886.34M | Rs3,722.90 | -0.36% |
| Alumis Inc.NasdaqGS: ALMS | $876.28M | $6.77 | -2.31% |
| Chongqing Lummy Pharmaceutical Co., Ltd.SZSE: 300006 | $875.23M | CN¥5.56 | +2.02% |
| Wuhan Keqian Biology Co.,LtdSHSE: 688526 | $853.44M | CN¥12.34 | +1.31% |
| HK inno.N CorporationKOSDAQ: A195940 | $844.58M | ₩40,150.00 | +3.35% |
Figures last refreshed Oct 4, 2026.